80
Participants
Start Date
February 1, 2022
Primary Completion Date
January 1, 2024
Study Completion Date
January 31, 2026
Blinatumomab
Blinatumomab will be bridged to conventional BUCY conditioning regimen.
Conventional therapy
Control group will be given conventional BUCY conditioning regimen.
RECRUITING
The first affiliated hospital of Soochow University, Suzhou
Fujian Medical University Union Hospital
OTHER
Zhongda Hospital
OTHER
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER
The First People's Hospital of Changzhou
OTHER
Wuxi People's Hospital
OTHER
First Affiliated Hospital of Wannan Medical College
OTHER
The First Affiliated Hospital of Soochow University
OTHER